2023
DOI: 10.1002/advs.202206615
|View full text |Cite
|
Sign up to set email alerts
|

CoVSense: Ultrasensitive Nucleocapsid Antigen Immunosensor for Rapid Clinical Detection of Wildtype and Variant SARS‐CoV‐2

Abstract: The widespread accessibility of commercial/clinically-viable electrochemical diagnostic systems for rapid quantification of viral proteins demands translational/preclinical investigations. Here, Covid-Sense (CoVSense) antigen testing platform; an all-in-one electrochemical nano-immunosensor for sample-to-result, self-validated, and accurate quantification of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N)-proteins in clinical examinations is developed. The platform's sensing s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…For rapid and POC assays, antibody-based sensors are typically recommended to be stored at 4 °C [ 46 , 47 ] and used within a certain time after unpacking. To further evaluate the stability of the mAb-functionalized sensor under environmental condition of 25 °C and 50% relative humidity, 5 test groups were designed to detect the same concentration of the target.…”
Section: Resultsmentioning
confidence: 99%
“…For rapid and POC assays, antibody-based sensors are typically recommended to be stored at 4 °C [ 46 , 47 ] and used within a certain time after unpacking. To further evaluate the stability of the mAb-functionalized sensor under environmental condition of 25 °C and 50% relative humidity, 5 test groups were designed to detect the same concentration of the target.…”
Section: Resultsmentioning
confidence: 99%